Stockscreener 앱 받기
1.97
1.03%
0.02
시간 외 거래:
1.96
-0.01
-0.51%
Citius Oncology Inc 주식(CTOR)의 최신 뉴스
What is Citius Oncology Inc. company’s growth strategyCapitalize on market momentum for profits - jammulinksnews.com
What is the risk reward ratio of investing in Citius Oncology Inc. stockMassive stock growth - jammulinksnews.com
What are the latest earnings results for Citius Oncology Inc.Discover stocks with explosive upside potential - jammulinksnews.com
Does Citius Oncology Inc. stock perform well during market downturnsInvest smarter with data-backed insights - jammulinksnews.com
Is Citius Oncology Inc. a good long term investmentExceptional trading performance - Autocar Professional
What drives Citius Oncology Inc. stock priceDynamic growth stocks - Autocar Professional
Citius Oncology Announces Closing of $9.0 Million Public Offering - StreetInsider
Citius Oncology Inc. Stock Analysis and ForecastMarket-leading capital gains - Autocar Professional
What analysts say about Citius Oncology Inc. stockFree Wealth Management Insights - jammulinksnews.com
Citius Oncology shares rise 1.31% after-hours after closing a $9.0 million public offering. - AInvest
Should I buy Citius Oncology Inc. stock before earningsShort Term High Return Strategy - Newser
Citius Oncology Completes $9M Public Offering - TipRanks
Citius Oncology launches $15M equity and warrant offering; shares down - MSN
Citius Oncology closes $9 million public offering to support LYMPHIR - Investing.com Australia
Citius Oncology closes $9 million public offering to support LYMPHIR By Investing.com - Investing.com Nigeria
Citius Oncology Raises $9M in Public Offering for LYMPHIR Commercialization - AInvest
Citius Oncology Announces Closing Of $9.0 Million Public Offering - Barchart.com
Citius Oncology Announces Pricing Of $9M "Reasonable Best-Efforts" Public Offering Of 6,818,182 Shares Of Common Stock And Warrants To Purchase Shares Of Common Stock At A Public Offering Price Of $1.32 Per Share - 富途牛牛
Citius Pharmaceuticals shares fall 1.34% after-hours following Citius Oncology's public offering. - AInvest
Citius Oncology’s Chances: Time to Invest? - StocksToTrade
Citius Oncology Announces Pricing of $9.0 Million Public Offering - Finansavisen
Citius Oncology Soars 35.06% on Distribution Deal - AInvest
Citius Oncology Soars 12.34% on Expanded Lymphir Distribution - AInvest
Citius Oncology stock rises after expanding LYMPHIR distribution network - Investing.com
What makes Citius Oncology Inc. stock price move sharplySecure Your Capital Strategy - Newser
Why Citius Oncology Inc. stock attracts strong analyst attentionEarly Breakout Tracker - Newser
Cencora (COR) Partners With Citius Oncology For Immunotherapy Distribution Expansion - simplywall.st
Citius Oncology Shares Climb Following Expansion of LYMPHIR Distribution Network - MSN
Citius Oncology (CTOR): Is LYMPHIR's Launch Priced for Success? - AInvest
Citius Oncology: Is A Lymphir Launch Coming Too Late? - Seeking Alpha
Citius Pharmaceuticals (CTXR) Surges on New Distribution Deal - GuruFocus
Citius Oncology stock rises after expanding LYMPHIR distribution network By Investing.com - Investing.com Nigeria
2.82%
0.27%
자본화:
|
볼륨(24시간):